Skip to main content

Table 3 Summary of serious/non-serious adverse events (AEs) by system organ class (SOC) in the intention-to-treat population (N = 91)

From: The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS

Serious/non-serious AEs by SOC

n (%)

Bradycardia

1 (1.1)

Cardio-respiratory arrest

2 (2.2)

Intestinal obstruction

1 (1.1)

Appendicitis

1 (1.1)

Septic shock

1 (1.1)

Klebsiella spp. bacteremia

1 (1.1)

Hyperkalemia

2 (2.2)

Postural dizziness

1 (1.1)

Epistaxis

1 (1.1)

Acute respiratory failure

2 (2.2)

  1. None was assessed as treatment related